Published on
Nov 10, 2026
FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications
The US Food and Drug Administration (FDA) has issued a new warning on GLP-1 medications – which can facilitate weight loss – over a rare eye condition that could lead to sudden and permanent blindness. On Monday, the FDA announced that it is requiring all …
Source:
The Guardian
-
Center-left
